SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)

CUSIP: 78397T202

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+6,119,671
SEC-reported price per share
$3.74
Number of holders
48
Value change
+$25,718,819
Number of buys
31
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
76,568,369

Security key

78397T202

Report period

Q4 2025

Institutions

48

Top holders

10

Ownership snapshot

Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 10% 13D/G row: Vivo Opportunity Fund Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership Top 5
Vivo Opportunity Fund Holdings, L.P. 10%
Woodline Partners LP 9.9%
Commodore Capital LP 9.9%
BIOTECHNOLOGY VALUE FUND L P 9.1%
RTW INVESTMENTS, LP 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vivo Opportunity Fund Holdings, L.P.
13D/G
10%
$54,973,720
25,931,000 shares
$0 29 Sep 2025
Woodline Partners LP
13D/G 13F
Company
9.9%
$14,323,021
7,125,881 shares
$0 30 Sep 2025
Commodore Capital LP
13D/G 13F
Company
9.9%
$9,588,711
4,522,977 shares
$0 26 Sep 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
9.1%
$18,761,910
4,761,906 shares
-$1,598,505 31 Dec 2025
RTW INVESTMENTS, LP
13D/G
3.2%
$6,253,970
1,587,302 shares
+$2,218,090 31 Dec 2025
Vivo Capital, LLC
13F
Company
13F
15%
$22,954,200
11,420,000 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
48
Shares
36,342,111
Rows available
48
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
34
Q4 2025 holders
48
Holder diff
14
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .